|
2025 Journal Article Prediction and Longer-Term Outcomes of All-cause and Cardiovascular Mortality in the HEART-FID TrialEzekowitz, Justin A., Mulder, Hillary, Mentz, Robert J., Butler, Javed, De Pasquale, Carmine G., Lewis, Gregory D., O'Meara, Eileen, Ponikowski, Piotr, Troughton, Richard W., Wong, Yee Weng, Adamczyk, Robert, Numan, Syed, Blackman, Nicole, Rockhold, Frank W. and Hernandez, Adrian F. (2025). Prediction and Longer-Term Outcomes of All-cause and Cardiovascular Mortality in the HEART-FID Trial. Journal of Cardiac Failure. doi: 10.1016/j.cardfail.2025.01.009 |
|
2024 Journal Article Hierarchical end points in prior heart failure trials and the HEART-FID TrialHarrington, Josephine, Mentz, Robert J., Rockhold, Frank W., Garg, Jyotsna, Butler, Javed, De Pasquale, Carmine G., Ezekowitz, Justin A., Lewis, Gregory D., O’Meara, Eileen, Ponikowski, Piotr, Troughton, Richard W., Wong, Yee W., Adamczyk, Robert, Storie, Tatyana, Blackman, Nicole and Hernandez, Adrian F. (2024). Hierarchical end points in prior heart failure trials and the HEART-FID Trial. Circulation: Heart Failure, 17 (2) e010676, 169-177. doi: 10.1161/circheartfailure.123.010676 |
|
2024 Journal Article Characterization of serum phosphate levels over time with intravenous ferric carboxymaltose versus placebo as treatment for heart failure with reduced ejection fraction and iron deficiency: An exploratory prospective substudy from HEART-FIDNouhravesh, Nina, Garg, Jyotsna, Rockhold, Frank W., De Pasquale, Carmine G., O'Meara, Eileen, Lewis, Gregory D., Butler, Javed, Harrington, Josephine, Ezekowitz, Justin A., Ponikowski, Piotr, Troughton, Richard W., Wong, Yee Weng, Blackman, Nicole, Numan, Syed, Adamczyk, Robert, Hernandez, Adrian F. and Mentz, Robert J. (2024). Characterization of serum phosphate levels over time with intravenous ferric carboxymaltose versus placebo as treatment for heart failure with reduced ejection fraction and iron deficiency: An exploratory prospective substudy from HEART-FID. European Journal of Heart Failure. doi: 10.1002/ejhf.3348 |
|
2023 Journal Article Baseline characteristics of patients in the randomized study to investigate the efficacy and safety of ferric carboxymaltose as treatment for heart failure with iron deficiency: HEART-FID trialHarrington, Josephine, Mentz, Robert J., Rockhold, Frank W., Garg, Jyotsna, Butler, Javed, De Pasquale, Carmine G., Ezekowitz, Justin A., Lewis, Gregory D., O'Meara, Eileen, Ponikowski, Piotr, Troughton, Richard W., Wong, Yee Weng, Adamczyk, Robert, Blackman, Nicole and Hernandez, Adrian F. (2023). Baseline characteristics of patients in the randomized study to investigate the efficacy and safety of ferric carboxymaltose as treatment for heart failure with iron deficiency: HEART-FID trial. American Heart Journal, 266, 25-31. doi: 10.1016/j.ahj.2023.08.005 |
|
2023 Journal Article ST elevation myocardial infarction complicated by cardiogenic shock: Systematic review of survival predictorsKhoo, John King, Trewin, Benjamin P., Adji, Audrey, Wong, Yee Weng and Hungerford, Sara (2023). ST elevation myocardial infarction complicated by cardiogenic shock: Systematic review of survival predictors. American Journal of Medicine Open, 10 100057, 1-8. doi: 10.1016/j.ajmo.2023.100057 |
|
2023 Journal Article Ferric Carboxymaltose in Heart Failure with Iron DeficiencyMentz, Robert J, Garg, Jyotsna, Rockhold, Frank W, Butler, Javed, De Pasquale, Carmine G, Ezekowitz, Justin A, Lewis, Gregory D, O'Meara, Eileen, Ponikowski, Piotr, Troughton, Richard W, Wong, Yee Weng, She, Lilin, Harrington, Josephine, Adamczyk, Robert, Blackman, Nicole, Hernandez, Adrian F and for the HEART-FID Investigators (2023). Ferric Carboxymaltose in Heart Failure with Iron Deficiency. The New England Journal of Medicine, 389 (11), 975-986. doi: 10.1056/NEJMoa2304968 |
|
2023 Journal Article Ultrasound Enhancing Agents with Transthoracic Echocardiography for Maximal Wall Thickness in Hypertrophic CardiomyopathyBois, John P., Ayoub, Chadi, Geske, Jeffrey B., Wong, Yee Weng, Abbasi, Muhannad A., Foley, Thomas A., Mulvagh, Sharon L., Scott, Christopher G., Ommen, Steve R. and Pellikka, Patricia A. (2023). Ultrasound Enhancing Agents with Transthoracic Echocardiography for Maximal Wall Thickness in Hypertrophic Cardiomyopathy. Mayo Clinic Proceedings: Innovations, Quality & Outcomes, 7 (4), 309-319. doi: 10.1016/j.mayocpiqo.2023.06.002 |
|
2022 Journal Article Prognostic Value of Left and right ventricular deformation strain analysis on Acute Cellular rejection in Heart Transplant recipients: A 6-year outcome studyChamberlain, Robert, Edwards, Natalie F. A., Doyle, Samantha N., Wong, Yee Weng, Scalia, Gregory M., Sabapathy, Surendran and Chan, Jonathan (2022). Prognostic Value of Left and right ventricular deformation strain analysis on Acute Cellular rejection in Heart Transplant recipients: A 6-year outcome study. International Journal of Cardiovascular Imaging, 38 (11), 2271-2281. doi: 10.1007/s10554-022-02586-z |
|
2021 Journal Article Who ‘nose’, is it the angiotensin receptor neprilysin inhibitor?: a case series of persistent nasal pruritus in heart failure patients receiving sacubitril/valsartanGan, Jaclyn, Rheault, Haunnah and Wong, Yee Weng (2021). Who ‘nose’, is it the angiotensin receptor neprilysin inhibitor?: a case series of persistent nasal pruritus in heart failure patients receiving sacubitril/valsartan. European Heart Journal - Case Reports, 5 (12) ytab506, ytab506. doi: 10.1093/ehjcr/ytab506 |
|
2021 Journal Article Randomized placebo-controlled trial of ferric carboxymaltose in heart failure with iron deficiency: rationale and designMentz, Robert J., Ambrosy, Andrew P., Ezekowitz, Justin A., Lewis, Gregory D., Butler, Javed, Wong, Yee Weng, De Pasquale, Carmine G., Troughton, Richard W., O’Meara, Eileen, Rockhold, Frank W., Garg, Jyostna, Samsky, Marc D., Leloudis, Dianne, Dugan, Michael, Mundy, Linda M., Hernandez, Adrian F. and on behalf of the HEART-FID Trial Investigators (2021). Randomized placebo-controlled trial of ferric carboxymaltose in heart failure with iron deficiency: rationale and design. Circulation: Heart Failure, 14 (5) e008100, 596-603. doi: 10.1161/circheartfailure.120.008100 |
|
2021 Journal Article Effects of omecamtiv mecarbil on failing human ventricular trabeculae and interaction with (−)‐noradrenalineDashwood, Alexander, Cheesman, Elizabeth, Wong, Yee Weng, Haqqani, Haris, Beard, Nicole, Hay, Karen, Spratt, Melanie, Chan, Wandy and Molenaar, Peter (2021). Effects of omecamtiv mecarbil on failing human ventricular trabeculae and interaction with (−)‐noradrenaline. Pharmacology Research and Perspectives, 9 (3) e00760, e00760. doi: 10.1002/prp2.760 |
|
2021 Journal Article Hypophosphatemia is common after intravenous ferric carboxymaltose infusion among patients with symptomatic heart failure with reduced ejection fractionDashwood, Alexander, Vale, Cassandra, Laher, Shaaheen, Chui, Fiona, Hay, Karen and Wong, Yee Weng (2021). Hypophosphatemia is common after intravenous ferric carboxymaltose infusion among patients with symptomatic heart failure with reduced ejection fraction. Journal of Clinical Pharmacology, 61 (4), 515-521. doi: 10.1002/jcph.1754 |
|
2020 Journal Article A rare case of severe nontropical isolated right ventricular endomyocardial fibrosisLaher, Shaaheen, Wong, Yee Weng, Platts, David, Prabhu, Anil, Thomson, Bruce, Hamilton-Craig, Christian, Godbolt, David, Cheesman, Elizabeth and Dashwood, Alexander (2020). A rare case of severe nontropical isolated right ventricular endomyocardial fibrosis. JACC: Case Reports, 2 (13), 2078-2084. doi: 10.1016/j.jaccas.2020.09.042 |
|
2020 Journal Article Correction to “Understanding How Phosphorylation and Redox Modifications Regulate Cardiac Ryanodine Receptor Type 2 Activity to Produce an Arrhythmogenic Phenotype in Advanced Heart Failure”Dashwood, Alexander, Beard, Nicole, Wong, Yee Weng, Haqqani, Haris, Cheesman, Elizabeth and Molenaar, Peter (2020). Correction to “Understanding How Phosphorylation and Redox Modifications Regulate Cardiac Ryanodine Receptor Type 2 Activity to Produce an Arrhythmogenic Phenotype in Advanced Heart Failure”. ACS Pharmacology and Translational Science, 3 (6), 1422-1422. doi: 10.1021/acsptsci.0c00148 |
|
2020 Journal Article Understanding how phosphorylation and redox modifications regulate cardiac ryanodine receptor type 2 activity to produce an arrhythmogenic phenotype in advanced heart failureDashwood, Alexander, Cheesman, Elizabeth, Beard, Nicole, Haqqani, Haris, Wong, Yee Weng and Molenaar, Peter (2020). Understanding how phosphorylation and redox modifications regulate cardiac ryanodine receptor type 2 activity to produce an arrhythmogenic phenotype in advanced heart failure. ACS Pharmacology and Translational Science, 3 (4) acsptsci.0c00003, 563-582. doi: 10.1021/acsptsci.0c00003 |
|
2020 Journal Article Impact of patient and model of care factors on titration and tolerability of sacubitril/valsartan: an early Australian real-world experienceDashwood, Alexander, Vale, Cassandra, Laher, Shaaheen, Chui, Fiona, Rheault, Haunnah, Gan, Jaclyn and Wong, Yee Weng (2020). Impact of patient and model of care factors on titration and tolerability of sacubitril/valsartan: an early Australian real-world experience. Heart, Lung and Circulation, 29 (11), 1688-1695. doi: 10.1016/j.hlc.2020.03.008 |
|
2019 Journal Article Orthotopic cardiac transplantation for Chagas cardiomyopathy in AustraliaRausch, Karen, Lau, Katherine, Ulett, Kimberly, Chan, Wandy, Javorsky, George, Wong, Yee W., Thompson, Bruce, Pauli, John, McKenzie, Scott, Horvath, Robert and Platts, David (2019). Orthotopic cardiac transplantation for Chagas cardiomyopathy in Australia. Internal Medicine Journal, 49 (9), 1194-1195. doi: 10.1111/imj.14421 |
|
2018 Journal Article Effects of once-weekly exenatide on clinical outcomes in patients with preexisting cardiovascular disease: prespecified analysis from EXSCELMentz, Robert J., Thompson, Vivian P., Aguilar, David, Choi, Jasmine, Gustavson, Stephanie M., Iqbal, Nayyar, Kong, Alice P., Ohman, Peter, Sattar, Naveed, Scott, Russell S., Wong, Yee Weng, Holman, Rury R. and Hernandez, Adrian F. (2018). Effects of once-weekly exenatide on clinical outcomes in patients with preexisting cardiovascular disease: prespecified analysis from EXSCEL. Circulation, 138 (22), 2576-2578. doi: 10.1161/CIRCULATIONAHA.118.036811 |
|
2018 Journal Article Right heart catheterisation: how to do itKrishnan, Anish, Markham, Ryan, Savage, Michael, Wong, Yee-Weng and Walters, Darren (2018). Right heart catheterisation: how to do it. Heart Lung and Circulation, 28 (4), 1-8. doi: 10.1016/j.hlc.2018.08.005 |
|
2017 Journal Article Effects of once-weekly exenatide on cardiovascular outcomes in type 2 diabetesHolman, Rury R., Bethel, M. Angelyn, Mentz, Robert J., Thompson, Vivian P., Lokhnygina, Yuliya, Buse, John B., Chan, Juliana C., Choi, Jasmine, Gustavson, Stephanie M., Iqbal, Nayyar, Maggioni, Aldo P., Marso, Steven P., Öhman, Peter, Pagidipati, Neha J., Poulter, Neil, Ramachandran, Ambady, Zinman, Bernard, Hernandez, Adrian F., for the EXSCEL Study Group and Wong, Yee W. (2017). Effects of once-weekly exenatide on cardiovascular outcomes in type 2 diabetes. New England Journal of Medicine, 377 (13), 1228-1239. doi: 10.1056/nejmoa1612917 |
